{"filing":{"accession_number":"0001104659-26-083702","cik":"0001962738","ticker":"CASIF","company_name":"CASI Pharmaceuticals, Inc.","form":"6-K","filing_date":"2026-07-15","report_date":null,"primary_document":"tm2620566d1_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1962738/000110465926083702/tm2620566d1_6k.htm"},"events":[{"id":18001,"run_id":16155,"accession_number":"0001104659-26-083702","anchor_item_number":null,"event_type":"material_litigation","event_domain":"legal","is_material":true,"confidence":0.92,"summary":"The 6-K announces the final award in an arbitration proceeding against Juventas Co., Ltd. before the Hong Kong International Arbitration Centre. The tribunal rejected all of Juventas's breach allegations, determined Juventas wrongfully terminated the parties' agreements regarding CNCT-19 commercialization, and awarded CASI \"well over RMB 100 million\" in wasted costs, interest, tribunal costs, and legal fees. This is a material litigation settlement/award that would affect a reasonable investor's assessment of the company's financial position and legal standing.","company_name":"CASI Pharmaceuticals, Inc.","ticker":"CASIF","filing_date":"2026-07-15","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":16679,"accession_number":"0001104659-26-083702","item_number":null,"item_title":null,"event_type":"material_litigation","event_domain":"legal","is_material":true,"confidence":0.92,"reasoning":"The 6-K announces the final award in an arbitration proceeding against Juventas Co., Ltd. before the Hong Kong International Arbitration Centre. The tribunal rejected all of Juventas's breach allegations, determined Juventas wrongfully terminated the parties' agreements regarding CNCT-19 commercialization, and awarded CASI \"well over RMB 100 million\" in wasted costs, interest, tribunal costs, and legal fees. This is a material litigation settlement/award that would affect a reasonable investor's assessment of the company's financial position and legal standing.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-15T10:31:44.769809+00:00","company_name":"CASI Pharmaceuticals, Inc.","ticker":"CASIF","filing_date":"2026-07-15"}]}